Hepato-gastroenterology · 2008
Clinical characteristics of Helicobacter pylori-negative duodenal ulcer disease.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Chen Tseng-Shing, Chang Full-Young
Аннотация
BACKGROUND/AIMS: Previous data on H. pylori-negative duodenal ulcer (DU) are limited due to different exclusion criteria adopted. In this study we attempted to clarify the characteristics of H. pylori-negative DU disease from patients referred for endoscopy.
METHODOLOGY: We recruited patients with DU disease and without H. pylori infection as confirmed by biopsy urease and 13C-urea breath tests. With each patient we carried out a structured personal interview including basic demographic and clinical data, personal habits, use of NSAIDs/aspirin, antibiotics, proton pump inhibitors (PPI) and anti-Hp therapy. If patients used antibiotics or PPI, a urea breath test was performed four or two weeks after discontinuation, respectively.
RESULTS: The mean age of patients with H. pylori-negative DU was 60.3 years (20-87). Among the 66 H. pylori-negative DU patients, 34 (51.5%) had reported use of NSAID/aspirin, 24 (36.4%) had a history of previous eradication therapy. Among the 32 non-H. pylori and non-NSAID DU cases, five (15.6%) had psychophysical stress, four (12.6%) had co-morbid illnesses, and two (6.3%) were alcoholics.
CONCLUSIONS: NSAID/aspirin use is the most common cause of H. pylori-negative DU disease. Psychophysical stress, co-morbid illnesses, and alcohol abuse appear to be associated with the development of non-H. pylori and non-NSAID DU disease.
METHODOLOGY: We recruited patients with DU disease and without H. pylori infection as confirmed by biopsy urease and 13C-urea breath tests. With each patient we carried out a structured personal interview including basic demographic and clinical data, personal habits, use of NSAIDs/aspirin, antibiotics, proton pump inhibitors (PPI) and anti-Hp therapy. If patients used antibiotics or PPI, a urea breath test was performed four or two weeks after discontinuation, respectively.
RESULTS: The mean age of patients with H. pylori-negative DU was 60.3 years (20-87). Among the 66 H. pylori-negative DU patients, 34 (51.5%) had reported use of NSAID/aspirin, 24 (36.4%) had a history of previous eradication therapy. Among the 32 non-H. pylori and non-NSAID DU cases, five (15.6%) had psychophysical stress, four (12.6%) had co-morbid illnesses, and two (6.3%) were alcoholics.
CONCLUSIONS: NSAID/aspirin use is the most common cause of H. pylori-negative DU disease. Psychophysical stress, co-morbid illnesses, and alcohol abuse appear to be associated with the development of non-H. pylori and non-NSAID DU disease.